NIO
NIO Inc.
NIO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
ZKH
ZKH Group Limited
There isn't enough reported data to score ZKH yet.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
ZKH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Stable | |
| Unavailable |
ZKH's cash flow is currently stable, but its revenue and profitability are under pressure. There isn't enough data to rate its balance sheet.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
ZKH PE Valuation
ZKH has no meaningful PE right now: it lost money over the past year.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
ZKH Forward outlook
There aren't enough analyst estimates for ZKH to show an outlook.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
ZKH Earnings Per Share
ZKH has the edge over NIO in the latest year-over-year earnings comparison.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over ZKH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
ZKH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $365.7M | +12% |
| Q1 2026 | $317.2M | +9.2% |
| Q4 2025 | $383.8M | -70% |
| Q3 2025 | $349.4M | +2.1% |
| Q2 2025 | $325.2M | -3.7% |
| Q1 2025 | $290.4M | +4% |
| Q4 2024 | $1.3B | +245% |
| Q3 2024 | $342.3M | +0.7% |
ZKH's revenue is recovering but still below its 2024 peak: $366M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 0.2% | +3.5 points |
| Q1 2026 | -1.1% | +3.1 points |
| Q4 2025 | -1.1% | +2.7 points |
| Q3 2025 | -1.4% | +3.2 points |
| Q2 2025 | -3.3% | -0.1 points |
| Q1 2025 | -4.2% | +2.8 points |
| Q4 2024 | -3.8% | -3.6 points |
| Q3 2024 | -4.6% | +0.7 points |
ZKH has the edge over NIO on profitability, with a higher operating margin.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO has the edge over ZKH on cash flow, with more consistent year-over-year improvement.
ZKH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | +$12.5M |
| Q3 2024 | $0 | $0 |
ZKH's free cash flow was $0 over the past year, against $0 the year before.
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has 2.5B diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
ZKH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -59K shares |
| 1 year | -1.6% | -72.8K shares |
| 3 years | +386% | +3.7M shares |
ZKH has the edge over NIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ZKH Net Leverage
ZKH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
ZKH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.8 | Oversold |
| Stochastic | 6.5 | Oversold |
ZKH's weekly RSI is 20 (oversold) and its Stochastic is 7 (oversold).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
ZKH PE vs Consumer Cyclical Sector
ZKH has no meaningful PE right now: it lost money over the past year.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
ZKH has stronger trend alignment. NIO is above 0 of 5 weekly averages versus ZKH above 0 of 4.
ZKH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.91 | 33% below |
| 20 week MA | $2.48 | 48% below |
| 50 week MA | $2.88 | 56% below |
| 100 week MA | $3.02 | 58% below |
ZKH is in a downtrend: it's below all four of its weekly moving averages, and 58% below its 100-week average.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO has the edge over ZKH on returns for 2026, with the stronger performance.
ZKH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $15.5 | $16.3 | +5.2% |
| 2024 | $16.3 | $3.35 | -79% |
| 2025 | $3.35 | $3.65 | +9% |
| 2026 YTD | $3.65 | $1.28 | -65% |
ZKH is down 65% so far in 2026, after finishing higher in two of the previous three years.